PPAR-γ activation can inhibit cell proliferation and migration, and promote CRC cell differentiation and apoptosis.39–41 Interestingly, serum PPAR-γ in CRC patients was significantly reduced and PPAR-γ showed a significant negative association with CRC in the current study. Here, PPARG is linked to colorectal carcinoma.